Clinical Trial Update: Depression and Interleukin-6 Production in Patients With Ovarian Epithelial Cancer

View source ↗

Summary

A clinical trial investigating depression and interleukin-6 production in patients with ovarian epithelial cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fatigue
• Major Depressive Disorder
• Ovarian Cancer
• Sleep Disorders

Snippet

Sponsor: Jonsson Comprehensive Cancer Center | Conditions: Depression, Fatigue | Status: WITHDRAWN